ZA200907240B - Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods - Google Patents

Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods

Info

Publication number
ZA200907240B
ZA200907240B ZA200907240A ZA200907240A ZA200907240B ZA 200907240 B ZA200907240 B ZA 200907240B ZA 200907240 A ZA200907240 A ZA 200907240A ZA 200907240 A ZA200907240 A ZA 200907240A ZA 200907240 B ZA200907240 B ZA 200907240B
Authority
ZA
South Africa
Prior art keywords
compositions
treatment
melanomas
procedures
prepare
Prior art date
Application number
ZA200907240A
Other languages
English (en)
Inventor
Jose Mordoh
Maria Marcela Barrio
Euw Erika Maria Von
Original Assignee
Consejo Nac Invest Cient Tec
Fundacion Sales
Inis Biotech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Nac Invest Cient Tec, Fundacion Sales, Inis Biotech Llc filed Critical Consejo Nac Invest Cient Tec
Publication of ZA200907240B publication Critical patent/ZA200907240B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • A61K39/464491—Melan-A/MART
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • A61K39/464492—Glycoprotein 100 [Gp100]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200907240A 2007-04-11 2009-10-16 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods ZA200907240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070101520A AR060424A1 (es) 2007-04-11 2007-04-11 Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento

Publications (1)

Publication Number Publication Date
ZA200907240B true ZA200907240B (en) 2010-07-28

Family

ID=39590605

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907240A ZA200907240B (en) 2007-04-11 2009-10-16 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods

Country Status (17)

Country Link
US (1) US8501168B2 (fr)
EP (1) EP2146742B1 (fr)
JP (1) JP5762738B2 (fr)
KR (1) KR101502518B1 (fr)
CN (1) CN101861163B (fr)
AR (1) AR060424A1 (fr)
AU (1) AU2008238909B2 (fr)
BR (1) BRPI0809767B1 (fr)
CA (1) CA2683629C (fr)
CO (1) CO6260100A2 (fr)
DK (1) DK2146742T3 (fr)
ES (1) ES2390130T3 (fr)
MX (1) MX2009010927A (fr)
NZ (1) NZ580533A (fr)
RU (1) RU2484134C2 (fr)
WO (1) WO2008126039A2 (fr)
ZA (1) ZA200907240B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6077735B2 (ja) * 2011-06-08 2017-02-08 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
CN105999249A (zh) 2011-10-20 2016-10-12 新干细胞肿瘤学有限责任公司 具有γ干扰素的抗原呈递癌症疫苗
JP6077757B2 (ja) * 2012-04-17 2017-02-08 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
JP5921386B2 (ja) * 2012-08-27 2016-05-24 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
CN103146641B (zh) * 2013-02-06 2015-03-25 云南中科灵长类生物医学重点实验室 多能干细胞的传代方法及其用途
CN104990781B (zh) * 2015-06-29 2018-02-16 中国医学科学院皮肤病研究所 黑素细胞免疫组化苏木素—甲苯胺蓝双重复染法
AU2020395765A1 (en) 2019-12-03 2022-06-16 Neuvogen, Inc. Tumor cell vaccines
RU2755233C1 (ru) * 2021-01-11 2021-09-14 Сергей Анатольевич Яргунин Способ лечения меланомы кожи IIb-IIc стадий
CN115074328A (zh) * 2022-06-21 2022-09-20 中国人民解放军空军军医大学 一种用于治疗黑素瘤的细胞株及其多效价全细胞疫苗与使用方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
CA2259140C (fr) * 1996-07-10 2008-09-30 Immunex Corporation Procede d'activation de cellules dendritiques
EP0929318B1 (fr) * 1996-08-16 2004-11-24 The Johns Hopkins University School Of Medicine Lignee cellulaire du melanome exprimant des antigenes heterophiles immunodominants et techniques d'utilisation
WO1999042564A2 (fr) * 1998-02-20 1999-08-26 The Rockefeller University Presentation des antigenes aux lymphocytes t au moyen de cellules d'apoptose
DK1224264T3 (da) * 1999-10-15 2010-05-10 Baylor Res Inst Anvendelse af allogene cellelinjer til at belaste antigenpræsenterende celler til at fremkomme med immunresponser
WO2001028583A2 (fr) * 1999-10-18 2001-04-26 St. Vincent's Hospital And Medical Center Of New York Vaccin contre le melanome
US7015205B1 (en) * 1999-10-18 2006-03-21 St. Vincent's Hospital And Medical Center Of New York Melanoma vaccine and methods of making and using same
US20030108527A1 (en) * 1999-12-28 2003-06-12 Tsukasa Seya Maturation-promoting agent for immature dendrtic cells
JP2004512030A (ja) * 2000-09-15 2004-04-22 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 特異的細胞溶解性ｔ細胞応答を誘導するための組成物および方法
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
IL140796A0 (en) * 2001-01-08 2002-02-10 Hadasit Med Res Service An autologous anti-cancer vaccine
EP1390064A4 (fr) * 2001-03-09 2006-10-18 Baylor Res Inst Methode de traitement de malignites par l'induction de reponses immunitaires dans le sang
WO2003020884A2 (fr) * 2001-08-14 2003-03-13 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Procede de generation rapide de cellules dentritique matures
WO2003057823A2 (fr) * 2001-11-07 2003-07-17 Mannkind Corporation Synchronisation d'epitope dans les cellules qui presentent des antigenes
RU2348418C2 (ru) * 2002-12-06 2009-03-10 Норсуэст Байотерапьютикс, Инк. Введение дендритных клеток, подвергнутых частичному созреванию in vitro, для лечения опухолей
AU2004239288B2 (en) * 2003-05-09 2010-01-28 Centocor, Inc. IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
JP5021309B2 (ja) * 2003-10-16 2012-09-05 ステファン ジョン ラルフ 免疫調節性組成物およびその使用方法
RU2262941C2 (ru) 2004-01-05 2005-10-27 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ иммунотерапии злокачественных опухолей головного мозга
US7850962B2 (en) * 2004-04-20 2010-12-14 Genmab A/S Human monoclonal antibodies against CD20
JP2007536932A (ja) * 2004-05-10 2007-12-20 マクロジェニクス，インコーポレーテッド ヒト化ＦｃγＲＩＩＢ特異的抗体とその利用法
RU2283129C1 (ru) 2004-12-24 2006-09-10 Сергей Викторович Луценко Белковопептидный противоопухолевый композит, клеточный препарат, активированный этим композитом, и способ профилактики или лечения опухолей

Also Published As

Publication number Publication date
AU2008238909A1 (en) 2008-10-23
BRPI0809767B1 (pt) 2022-04-12
CN101861163A (zh) 2010-10-13
CA2683629C (fr) 2016-06-21
CO6260100A2 (es) 2011-03-22
CN101861163B (zh) 2013-06-12
DK2146742T3 (da) 2012-10-22
MX2009010927A (es) 2010-02-11
ES2390130T3 (es) 2012-11-06
US8501168B2 (en) 2013-08-06
WO2008126039A2 (fr) 2008-10-23
EP2146742B1 (fr) 2012-07-11
RU2009141593A (ru) 2011-05-20
RU2484134C2 (ru) 2013-06-10
US20100183683A1 (en) 2010-07-22
JP5762738B2 (ja) 2015-08-12
NZ580533A (en) 2012-08-31
AR060424A1 (es) 2008-06-18
JP2010523141A (ja) 2010-07-15
CA2683629A1 (fr) 2008-10-23
BRPI0809767A2 (pt) 2014-09-23
EP2146742A2 (fr) 2010-01-27
WO2008126039A3 (fr) 2008-12-11
KR101502518B1 (ko) 2015-03-13
KR20090129501A (ko) 2009-12-16
AU2008238909B2 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
IL202015A0 (en) Methods and compositions for treating skin conditions
ZA200907240B (en) Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
EP2361089A4 (fr) Compositions et procédés pour le traitement d une fonction altérée de l' -synucléine
IL220129A (en) History of benzamide, preparations containing them and their use in the treatment of cancer
IL208458A0 (en) Compositions and methods for skin care
IL202329A0 (en) Methods and compositions for stimulating cells
HK1148906A1 (en) Compositions and methods for cancer treatment
EP2391344A4 (fr) Compositions pour le traitement des ongles et de la peau
EP2212440A4 (fr) Procédés et compositions destinés au diagnostic et au traitement de l'adénocarcinome de l' sophage
HK1159498A1 (en) Methods and compositions for the treatment of cancer
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
EP2124985A4 (fr) Méthodes et compositions destinées au traitement de neuropathies
HK1166305A1 (zh) 用於治療炎症的組合物及方法
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
GB0718446D0 (en) Compositions and methods for the treatment of infection
EP2429584A4 (fr) Procédés et compositions de traitement
EP2340027A4 (fr) Procédés et compositions destinés au traitement du cancer
EP2249789A4 (fr) Compositions et méthodes pour le traitement de la xérostomie
EP2209458A4 (fr) Compositions de traitement de la peau
IL214349A0 (en) Compositions and methods for the treatment of cancer
PT2403336E (pt) Composições de tratamento de plantas e métodos para a sua utilização
GB0909297D0 (en) Composition for the treatment of skin conditions
EP2437738A4 (fr) Procédés et compositions pour le traitement du cancer
EP2150270A4 (fr) Méthodes et compositions pour traiter le cancer
GB0718918D0 (en) Compositions and methods for treating skin conditions